Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GE HealthCare Technologies (GEHC) EBIT Margin (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of EBIT Margin readings, the most recent being 10.04% for Q1 2026.

  • On a quarterly basis, EBIT Margin fell 313.0% to 10.04% in Q1 2026 year-over-year; TTM through Mar 2026 was 12.63%, a 108.0% decrease, with the full-year FY2025 number at 13.4%, up 5.0% from a year prior.
  • EBIT Margin hit 10.04% in Q1 2026 for GE HealthCare Technologies, down from 14.51% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 15.74% in Q4 2022 to a low of 10.04% in Q1 2026.
  • Median EBIT Margin over the past 5 years was 13.06% (2025), compared with a mean of 13.01%.
  • Biggest five-year swings in EBIT Margin: skyrocketed 182bps in 2024 and later tumbled -313bps in 2026.
  • GE HealthCare Technologies' EBIT Margin stood at 15.74% in 2022, then dropped by -16bps to 13.23% in 2023, then rose by 14bps to 15.06% in 2024, then dropped by -4bps to 14.51% in 2025, then tumbled by -31bps to 10.04% in 2026.
  • The last three reported values for EBIT Margin were 10.04% (Q1 2026), 14.51% (Q4 2025), and 12.7% (Q3 2025) per Business Quant data.